Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
-
Australia's High Court rules against coal mine in landmark climate case
-
N. Korea's Kim pledges 'invariable support' in Putin birthday letter
-
Australia touts new funds for Pacific infrastructure at Fiji 'pre-COP'
-
OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
-
Eva Marie Saint, Oscar winner of Hollywood classics, dies at 102
-
Emotion, tears as Messi prepares for Argentina farewell
-
Australia probes app used in cheap smart glasses over privacy fears
-
Kane eyes Ronaldo record after matching England cap mark
-
England needed to 'move on' from World Cup pain, says Tuchel
-
Spain fight back to beat Croatia, Kane adds to record for England
-
O'Neill to stay at Celtic after period of "reflection"
-
Merino double helps Spain beat Croatia, reach Nations League quarters
-
Kane marks 125th England cap with Wembley Nations League double
-
US stocks hit fresh records as oil stabilizes on rising supplies
-
Quebec's incoming separatist leader wants to block Crown from swearing-in
-
As Messi bows out, Argentines say 'thank you'
-
Emmys gala will now stream its premier television awards
-
Ronaldo opens door for Portugal return, apologises for walkout
-
Paramount completes Warner Bros takeover, creating Skydance
-
'Nobody seems to care': Russian city shrugs off plague reports
-
Trump blames France unrest on Islam, migration
-
Hundreds arrested in French school protests as Macron summons ministers
-
Apple's Cook praises EU over efforts to protect children online
-
WADA seeks tough anti-doping stance from Kenya
-
Nobel winner Halzen says years of October 'misery' finally over
-
German ex-spy chief arrested for suspected espionage, treason
-
Quebec separatist win rattles Carney's unity push
-
Furyk vows US will 'do more' to end Ryder Cup losing streak
-
'Itching' for change: Shiffrin cuts back slaloms this season
-
Iyer hits ton as India hammer West Indies in T20 opener
-
'Gen Z has risen up': Tens of thousands mass for tense France school protests
-
Mandhana named India women's team captain after Kaur quits
-
Caribbean tourism hotspot loses men to Russian war machine
-
'The sound keeps coming back': children maimed in Ethiopia's Tigray clashes
-
Danish reservists practice war games to respond to 'aggression'
-
Paris Women's Fashion Week: the key trends
-
Bhuvneshwar returns to India's T20 squad for New Zealand tour
-
i-payout Introduces a New Approach to Payments, Closing the Beneficiary Information Gap
-
Asos says probing 'unauthorised activity' after phone alerts
-
New Generation of Crypto Miners Released by ASICID
-
Stocks climb as oil prices retreat under $100 per barrel
-
New investor forecasts LIV Golf teams could be worth $100 mn each
-
Neutrinos: space particles that change our view of universe
-
Shakira, Pique return to court over children visit arrangements
-
'Destined' Djokovic wins China Open, extending unbeaten record
-
Nobel physics prize hails 'ghostly messengers' from space
-
Iceland is 'critical outpost' for security, says Rubio during visit
-
France's Mistral unveils latest model in sovereign AI push
-
Israeli settlers beat AFP photographer covering West Bank
-
Stocks climb as oil prices retreat
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th
ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.
Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.
Sidoti Micro-Cap Virtual Conference Presentation Details
Dates: August 19-20, 2026
Date and Time: Wednesday, August 19, 2026, at 1:45 P.M. ET
Webcast: https://sidoti.zoom.us/webinar/register/WN_udxBu7lMQ9iYsAS6ydaFVA
One-on-One Meetings
Inspire will also host virtual one-on-ones with investors on Wednesday, August 19 and Thursday, August 20, 2026. To register for the presentation or one-on ones, visit https://sidoti.com/events.
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma has developed a patent-pending sublingual delivery technology that can deliver drugs to the body rapidly and precisely. This technology offers the potential to improve effectiveness and reduce side effects by going directly to the bloodstream and avoiding the gastrointestinal tract. Aspire Biopharma's delivery technology can be applied to many different active pharmaceutical ingredients (APIs) and other bioactive substances.
Aspire's subsidiary Dura Driver Control Systems is a leading designer and manufacturer of highly engineered automotive and industrial systems that facilitate electronic driver control and support migration toward vehicle electrification, safety, lightweighting, and sustainability. DCS maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.
For more information, please visit www.aspirebiolabs.com
Aspire Biopharma Holdings, Inc.
Contact:
PCG Advisory
Kevin McGrath
+1-646-418-7002
[email protected]
SOURCE: Aspire Biopharma Holdings, Inc.
View the original press release on ACCESS Newswire
W.Moreno--AT
